THE CAMBRIDGE PARTNERSHIP LIMITED - CAMBRIDGE
THE CAMBRIDGE PARTNERSHIP LIMITED - CAMBRIDGE
.
Overview
THE CAMBRIDGE PARTNERSHIP LIMITED is a company officer from Cambridge. This company officer is, or was, associated with at least 57 company roles.
Their most recent appointment, in our records, was to CENENTRY BIOSCIENCES LIMITED on 2024-04-11.
Address
The Dorothy Hodgkin Building, Babraham Research Campus
Babraham
Cambridge
CB22 3FH
United Kingdom
Map
Company Appointments - Current and Previous
| CompanyName | Company Status | Role | Appointed | Appointment Status | Assets |
|---|---|---|---|---|---|
| CENENTRY BIOSCIENCES LIMITED | Active | Corporate Secretary | 2024-04-11 | CURRENT | |
| PETALION THERAPEUTICS LIMITED | Active | Corporate Secretary | 2024-04-06 | CURRENT | |
| BPLETE LIMITED | Active | Corporate Secretary | 2023-10-28 | CURRENT | £1 cash, £1 equity |
| RECYCLE BIO LIMITED | Active | Corporate Secretary | 2023-10-26 | CURRENT | |
| INTERACT BIO LTD | Active | Corporate Secretary | 2023-09-15 | CURRENT | |
| TRUTINA THERAPEUTICS LTD | Active | Corporate Secretary | 2023-07-17 | CURRENT | |
| VIMELA THERAPEUTICS LIMITED | Active | Corporate Secretary | 2021-10-25 | CURRENT | |
| GRAEGIS PHARMACEUTICALS LIMITED | Active | Corporate Secretary | 2021-10-14 | CURRENT | |
| PODIUM BIO LIMITED | Active | Corporate Secretary | 2021-08-24 | CURRENT | |
| A BIO LIMITED | Active | Corporate Secretary | 2021-04-28 | CURRENT | £100 cash, £100 equity |
| PERFECT BALANCE BIO LIMITED | Active | Corporate Secretary | 2020-09-17 | CURRENT | |
| SDS THERAPEUTICS LIMITED | Active | Corporate Secretary | 2020-07-05 | CURRENT | £2,773,300 cash, £2,765,631 equity |
| BASTION THERAPEUTICS LIMITED | Active | Corporate Secretary | 2020-05-01 until 2023-08-22 | RESIGNED | £8,196 cash |
| CAMBRIDGE GLYCOSCIENCE LTD | Active | Corporate Secretary | 2020-04-23 | CURRENT | £3,082,517 cash, £-16,560,456 equity |
| IMHOTEX LIMITED | Active | Corporate Secretary | 2020-02-17 | CURRENT | £757,174 cash, £858,549 equity |
| HYDROGEN THERAPEUTICS LIMITED | Active | Corporate Secretary | 2019-09-25 | CURRENT | £46,187 cash, £56,224 equity |
| PANDEIA THERAPEUTICS LIMITED | Active | Corporate Secretary | 2019-08-09 | CURRENT | £796,269 cash, £829,602 equity |
| ROUND EARTH THERAPEUTICS LIMITED | Liquidation | Corporate Secretary | 2019-08-09 | CURRENT | £713,308 cash, £894,941 equity |
| ELEMENTS SQUARED LIMITED | Active | Corporate Secretary | 2019-06-25 | CURRENT | £464 cash, £43,059 equity |
| LITHIUM TX LIMITED | Active | Corporate Secretary | 2019-06-25 | CURRENT | £215 cash, £-2,347 equity |
| EPSILON-3 BIO LIMITED | Dissolved - no longer trading | Corporate Secretary | 2019-04-24 | CURRENT | £395,089 cash, £-2,673,671 equity |
| DC EUROPA LIMITED | Liquidation | Corporate Secretary | 2017-06-20 | CURRENT | £397,011 cash, £273,680 equity |
| CRITICAL PRESSURE LIMITED | Active | Corporate Secretary | 2017-06-20 | CURRENT | £246,520 cash, £331,277 equity |
| THE FOUNDRY (CAMBRIDGE) LIMITED | Active | Corporate Secretary | 2017-06-16 until 2018-04-30 | RESIGNED | £34,696 cash, £928,281 equity |
| ULTRAHUMAN SEVEN LIMITED | Liquidation | Corporate Secretary | 2017-03-03 until 2017-07-28 | RESIGNED | £78,828 cash, £93,726 equity |
| LOCKBODY THERAPEUTICS LTD | Active | Corporate Secretary | 2017-03-03 until 2017-07-28 | RESIGNED | £932,604 cash, £-1,759,462 equity |
| ULTRAHUMAN NINE LIMITED | Liquidation | Corporate Secretary | 2017-03-03 until 2017-07-28 | RESIGNED | £97,594 cash, £92,979 equity |
| ULTRAHUMAN THREE LIMITED | Dissolved - no longer trading | Corporate Secretary | 2017-03-03 until 2017-07-28 | RESIGNED | £7,465 cash, £7,224 equity |
| ULTRAHUMAN ELEVEN LIMITED | Dissolved - no longer trading | Corporate Secretary | 2017-03-03 until 2017-07-28 | RESIGNED | £87,776 cash, £282,752 equity |
| ULTRAHUMAN EIGHT LIMITED | Active | Corporate Secretary | 2017-03-03 until 2017-07-28 | RESIGNED | £4,313,392 cash, £4,328,884 equity |
| GRANULAR THERAPEUTICS LIMITED | Active | Corporate Secretary | 2017-03-03 until 2017-07-28 | RESIGNED | £4,463,582 cash, £4,475,715 equity |
| ULTRAHUMAN FOUR LIMITED | Dissolved - no longer trading | Corporate Secretary | 2017-03-03 until 2017-07-28 | RESIGNED | £89,072 cash, £-158,716 equity |
| ULTRAHUMAN FOURTEEN LIMITED | Liquidation | Corporate Secretary | 2017-03-03 until 2017-07-28 | RESIGNED | £32,684 cash, £141,557 equity |
| ULTRAHUMAN TEN LIMITED | Liquidation | Corporate Secretary | 2017-03-03 until 2017-07-28 | RESIGNED | £180,549 cash, £176,233 equity |
| ULTRAHUMAN THIRTEEN LIMITED | Liquidation | Corporate Secretary | 2017-03-03 until 2017-07-28 | RESIGNED | £34,930 cash, £30,565 equity |
| ULTRAHUMAN TWELVE LIMITED | Liquidation | Corporate Secretary | 2017-03-03 until 2017-07-28 | RESIGNED | £17,272 cash, £11,086 equity |
| ULTRAHUMAN TWO LIMITED | Dissolved - no longer trading | Corporate Secretary | 2017-03-01 until 2017-07-28 | RESIGNED | £19,660 cash, £-118,625 equity |
| ULTRAHUMAN ONE LIMITED | Liquidation | Corporate Secretary | 2017-02-28 until 2017-07-28 | RESIGNED | £69,036 cash, £-40,137 equity |
| REBALANCE (CAMBRIDGE) LIMITED | Dissolved - no longer trading | Corporate Secretary | 2016-12-06 | CURRENT | £395,914 cash, £533,987 equity |
| KAERUS BIOSCIENCE LIMITED | Active | Corporate Secretary | 2016-07-12 until 2017-12-03 | RESIGNED | £815,624 cash, £118,300 equity |
| KYMO THERAPEUTICS LIMITED | Active | Corporate Secretary | 2016-05-23 until 2023-07-31 | RESIGNED | £622 cash, £-64,475 equity |
| CORRECTA4 BIO LIMITED | Dissolved - no longer trading | Corporate Secretary | 2016-04-19 | CURRENT | £190,070 cash, £183,890 equity |
| MAVALON THERAPEUTICS LIMITED | Liquidation | Corporate Secretary | 2016-02-22 until 2017-08-11 | RESIGNED | £124,234 cash, £291,588 equity |
| ULTRAHUMAN LIMITED | Active | Corporate Secretary | 2015-11-24 until 2017-07-28 | RESIGNED | £16,688 cash, £19,343 equity |
| SUPERX LIMITED | Dissolved - no longer trading | Corporate Secretary | 2015-11-10 | CURRENT | £527,235 cash, £778,171 equity |
| HUMAN ANTIBODY FACTORY LIMITED | Dissolved - no longer trading | Corporate Secretary | 2015-10-06 | CURRENT | £826,970 cash, £809,702 equity |
| ABC MEDICINES LIMITED | Dissolved - no longer trading | Corporate Secretary | 2015-09-15 until 2018-04-30 | RESIGNED | £25,077 equity |
| STEALTHYX THERAPEUTICS LIMITED | Liquidation | Corporate Secretary | 2015-08-01 until 2017-10-30 | RESIGNED | £121,282 cash, £116,197 equity |
| CENTESSA PHARMACEUTICALS (MORPHOGEN-IX) LIMITED | Active | Corporate Secretary | 2015-07-15 until 2021-11-01 | RESIGNED | £3,042,378 cash, £3,578,170 equity |
| Z FACTOR LIMITED | Active | Corporate Secretary | 2014-10-21 until 2021-11-01 | RESIGNED | £1,195,577 cash, £1,897,448 equity |
| METHUSELAH HEALTH UK LIMITED | Active | Corporate Secretary | 2014-09-09 | CURRENT | £93,121 cash, £-1,234,550 equity |
| FUNXIONAL THERAPEUTICS LIMITED | Dissolved - no longer trading | Corporate Secretary | 2014-09-01 | CURRENT | |
| STX PHARMA LTD | Dissolved - no longer trading | Corporate Secretary | 2014-07-06 | CURRENT | |
| APCINTEX LIMITED | Active | Corporate Secretary | 2014-06-16 until 2021-11-01 | RESIGNED | £11,048,377 cash, £11,679,933 equity |
| JANPIX LIMITED | Dissolved - no longer trading | Corporate Secretary | 2013-09-27 until 2021-11-01 | RESIGNED | £6,844,993 cash, £7,010,510 equity |
| INHIBITAXIN LIMITED | Dissolved - no longer trading | Corporate Secretary | 2013-06-25 until 2014-02-05 | RESIGNED | £2,194 cash, £-596,480 equity |
Related People
| Name | Occupation | Address | No of Appointments |
|---|---|---|---|
| MR FRANCESCO DE RUBERTIS | Venture Capitalist | Altrincham, United Kingdom | 18 |
| DR NIGEL AARON PITCHFORD | Venture Capital - Managing Director | London, England | 12 |
| MR CHRISTIAN DE LA TOUR | Chairman | Slough, United Kingdom | 12 |
| DR KONSTANTINOS EFTHYMIOPOULOS | Chief Executive Officer | Cambridge | 2 |
| DR DAVID JOHN GRAINGER | Partner At Medicxi Ventures (Uk) Llp | Babraham, England | 25 |
| MR MARTIN WILLIAM EDWARDS | Director | Cambridge, England | 2 |
| DR DAVID JOHN GRAINGER | Director | Duxford, United Kingdom | 8 |
| MR SIMON LEMPRIERE WESTBROOK | Scientist | Sandwich, United Kingdom | 4 |
| MR ROMAN FLECK | Company Director | 1207 Geneva, Switzerland | 1 |
| DR KEVIN STUART JOHNSON | Venture Capital Investor | Mayfair, England | 29 |
| MICHELE OLLIER | Partner At Medicxi Ventures | Chatham | 4 |
| DR DANIEL BACH GONZALEZ | Company Director | London, England | 2 |
| DR. NANNA LIEBACH LUNEBORG | Investment Professional | 2900 Hellerup, Denmark | 1 |
| DR GIOVANNI MARIGGI | Investor | London, England | 3 |
| DR SAURABH SAHA | Company Director | Altrincham, United Kingdom | 12 |
| MS MARELLA THORELL | Accountant | Altrincham, United Kingdom | 11 |
| MR SANFORD ZWEIFACH | Company Director | London, United Kingdom | 2 |
| DAVID JOHN GRAINGER | Company Director | Cambridge, United Kingdom | 22 |
| DAVID MIN CHAO | Chief Administrative Officer, Centessa Pharmaceuti | Altrincham, United Kingdom | 9 |
| RICHARD MENZIUSO | Controller | Altrincham, United Kingdom | 11 |
Nearby People
| Name | Occupation | Address | No of Appointments |
|---|---|---|---|
| MR NICHOLAS ALEXANDER JAMES TAIT | Company Director | Cambridge, England | 15 |
| PROFESSOR ANTHONY SEGAL | Professor | Cambridge, United Kingdom | 6 |
| JEANNE ELIZABETH BOLGER | Venture Investor | Cambridge, England | 1 |
| NITZAN ROSENFELD | Scientist | Cambridge, England | 1 |
| ALLAN BRADLEY | Professor And Chief Scientific Officer | Cambridge, United Kingdom | 6 |
| DR JILL RECKLESS | Company Director | Cambridge, England | 7 |
| CHRISTINE MARTIN | Technology Transfer Manager | Cambridge, United Kingdom | 6 |
| DR ELAINE MCKILLIGIN | Company Director | Cambridge, England | 8 |
| MR TIMOTHY SHANNON | Cambridge, England | 1 | |
| DR ELAINE MCKILLIGIN | Cambridge, England | 1 |